Bausch Health
BHC
#4678
Rank
NZ$4.01 B
Marketcap
NZ$10.74
Share price
-1.79%
Change (1 day)
-2.53%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): NZ-$5.11

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is NZ-$5.25. In 2025 the company made an earnings per share (EPS) of NZ$0.75 an increase over its 2024 EPS that were of NZ-$0.21.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$5.11-784.16%
2025NZ$0.75-450%
2024NZ-$0.21-92.59%
2023NZ-$2.88160.89%
2022NZ-$1.10-76.64%
2021NZ-$4.7368.45%
2020NZ-$2.81-68.91%
2019NZ-$9.03-57.11%
2018NZ-$21.05-272.22%
2017NZ$12.22-199.29%
2016NZ-$12.31798.7%
2015NZ-$1.37-128.31%
2014NZ$4.84-204.62%
2013NZ-$4.62602.7%
2012NZ-$0.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.16-96.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.69-67.80%๐Ÿ‡บ๐Ÿ‡ธ USA